China Medical University, China
Clinical trials sponsored by China Medical University, China, explained in plain language.
-
New drug cocktail aims to keep aggressive lung cancer at bay
Disease control Not yet recruitingThis study is testing whether a combination of four drugs can help control extensive small cell lung cancer after initial treatment. The trial will involve about 31 adults who have not received prior treatment for this advanced cancer stage. Researchers want to see if this mainte…
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Virus-Based therapy targets Tough-to-Treat liver tumors
Disease control Not yet recruitingThis early-stage study is testing a new three-part treatment for people whose colorectal cancer has spread to the liver and other treatments have stopped working. The treatment combines a specially engineered virus designed to attack cancer cells with an immunotherapy drug and a …
Phase: PHASE1 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for Tough-to-Treat lung cancer: experimental combo targets tumors two ways
Disease control Not yet recruitingThis study is testing whether combining two drugs, sacituzumab tirumotecan and anlotinib, can help control advanced small cell lung cancer in patients whose cancer has worsened after their initial immunotherapy and chemotherapy treatment. The trial will enroll about 30 adults to …
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC